[DNLI] QoQ Quarter Result on 30-Sep-2017 [#Q3]

Stock
[DNLI] Denali Therapeutics Inc.
Announcement Date
29-Sep-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 1.31%
YoY- 28.64%
Quarter Report
DNLI's Result
DNLI's Financial Summary
View:
Show?
Quarter Result
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
Revenue 1,648 641 145,149 0 0 0 0 -
PBT -54,724 -23,678 -22,887 -21,844 -22,134 -21,320 -19,354 100.33%
Tax 0 0 -807 0 0 0 90 -
NP -54,724 -23,678 -22,887 -21,844 -22,134 -21,320 -19,354 100.33%
Tax Rate - - - - - - - -
Total Cost 56,372 24,319 168,036 21,844 22,134 21,320 19,354 104.35%
Ratio Analysis
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
NP Margin -3,320.63 -3,693.92 -15.77 0.00 0.00 0.00 0.00 -
Per Share
30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 CAGR
EPS -0.59 -0.26 -0.74 -0.27 -0.32 -2.36 -2.15 -57.87%
EPS Diluted -0.59 -0.26 -0.74 -0.27 -0.32 -2.36 -2.15 -57.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.